
	Home Site Map Contact Links Medical News

allergies and genetically modified organisms

Generic medication at fraction of the cost. Asthma.
Over 500 generics available for immediate delivery. Orders can be tracked online. 10% rebate for reorders. Full refund option.
Generics at fraction of the cost. Asthma.
Over 500 generics in stock. Licensed online pharmacy. No prescription needed. 10% rebate on reorders. Orders can be tracked online.
Discount accolate Prices
Discount prices - Buy Discount Prescription Drugs and Save Up To 80%.
Generic medication Low prices
Generic medication from Licensed online pharmacy FREE doctors consultation SAVE up to 70%
ACCOLATE: Find More Information here
Get best results for accolate. Get 10 most relevant accolate results.
Accolate
LowPriceShopper for all your shopping needs!
Buy Tramadol Online!
Tramadol. Offer review from dozens of shops. Daily list of the hottest offers on tramadol.
Accolate
LowPriceShopper for all your shopping needs!
Looking For Cheap Viagra??
Compare Prices For Viagra In Top 10 Online DrugStores. Daily Updated!
My EverydayHealth
Create a Homepage. Connect with others like you. Customize a meal plan - It's all free!

allergies and genetically modified organisms
DESCRIPTION
Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide allergies and genetically modified organisms. The molecular weight of zafirlukast is 575.7 and the structural formula is:

The empirical formula is: C 31 H 33 N 3 O 6 S

Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water allergies and genetically modified organisms. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone allergies and genetically modified organisms.

ACCOLATE is supplied as 10 and 20 mg tablets for oral administration allergies and genetically modified organisms.

Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide allergies and genetically modified organisms.

CLINICAL PHARMACOLOGY
Mechanism of Action
Zafirlukast is a selective and competitive receptor antagonist of leukotrieneD 4 and E 4 (LTD 4 and LTE 4 ), components of slow-reacting substance of anaphylaxis(SRSA) allergies and genetically modified organisms. Cysteinyl leukotriene production and receptor occupation have been correlatedwith the pathophysiology of asthma, including airway edema, smooth muscle constriction,and altered cellular activity associated with the inflammatory process, whichcontribute to the signs and symptoms of asthma allergies and genetically modified organisms. Patients with asthma were foundin one study to be 25-100 times more sensitive to the bronchoconstricting activityof inhaled LTD 4 than nonasthmatic subjects allergies and genetically modified organisms.

In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans allergies and genetically modified organisms. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs allergies and genetically modified organisms. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness allergies and genetically modified organisms.

In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges allergies and genetically modified organisms. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma allergies and genetically modified organisms. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma allergies and genetically modified organisms. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge allergies and genetically modified organisms.

Clinical Pharmacokinetics and Bioavailability:
Absorption
Zafirlukast is rapidly absorbed following oral administration allergies and genetically modified organisms. Peak plasma concentrationsare generally achieved 3 hours after oral administration allergies and genetically modified organisms. The absolute bioavailabilityof zafirlukast is unknown allergies and genetically modified organisms. In two separate studies, one using a high fat andthe other a high protein meal, administration of zafirlukast with food reducedthe mean bioavailability by approximately 40% allergies and genetically modified organisms.

Distribution
Zafirlukast is more than 99% bound to plasma proteins, predominantly albumin allergies and genetically modified organisms. The degree of binding was independent of concentration in the clinically relevantrange allergies and genetically modified organisms. The apparent steady-state volume of distribution (V SS /F) is approximately70 L, suggesting moderate distribution into tissues allergies and genetically modified organisms. Studies in rats using radiolabeledzafirlukast indicate minimal distribution across the blood-brain barrier allergies and genetically modified organisms.

Metabolism
Zafirlukast is extensively metabolized allergies and genetically modified organisms. The most common metabolic products arehydroxylated metabolites which are excreted in the feces allergies and genetically modified organisms. The metabolites ofzafirlukast identified in plasma are at least 90 times less potent as LTD 4receptor antagonists than zafirlukast in a standard in vitro test of activity allergies and genetically modified organisms. In vitro studies using human liver microsomes showed that the hydroxylated metabolitesof zafirlukast excreted in the feces are formed through the cytochrome P4502C9 (CYP2C9) pathway allergies and genetically modified organisms. Additional in vitro studies utilizing human liver microsomesshow that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymesat concentrations close to the clinically achieved total plasma concentrations(see Drug Interactions ) allergies and genetically modified organisms.

Excretion
The apparent oral clearance (CL/f) of zafirlukast is approximately 20 L/h allergies and genetically modified organisms. Studiesin the rat and dog suggest that biliary excretion is the primary route of excretion allergies and genetically modified organisms. Following oral administration of radiolabeled zafirlukast to volunteers, urinaryexcretion accounts for approximately 10% of the dose and the remainder is excretedin feces allergies and genetically modified organisms. Zafirlukast is not detected in urine allergies and genetically modified organisms.

In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma allergies and genetically modified organisms. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma allergies and genetically modified organisms. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg allergies and genetically modified organisms. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data allergies and genetically modified organisms. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% allergies and genetically modified organisms.

The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below allergies and genetically modified organisms.

Mean (% Coefficient of Variation) pharmacokinetic
parameters of zafirlukast following single 20 mg
oral dose administration to male volunteers (n=36) C max
ng/mL t max h AUC
ng·h/mL t 1/2
h CL/f
L/h
326 (31.0) 2 (0.5-5.0) 1137 (34) 13.3 (75.6) 19.4 (32)
1 Median and range

Special Populations
Gender: The pharmacokinetics of zafirlukast are similar in males and females allergies and genetically modified organisms. Weight-adjusted apparent oral clearance does not differ due to gender allergies and genetically modified organisms.

Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed allergies and genetically modified organisms.

Elderly: The apparent oral clearance of zafirlukast decreases with age allergies and genetically modified organisms. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients allergies and genetically modified organisms.

Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained:

Parameter Children age
5-6 years
Mean (% Coefficient
of Variation) Children age
7-11 years
Mean (% Coefficient
of Variation)
C max (ng/mL) 756 (39%) 601 (45%)
AUC (ng·h/mL) 2458 (34%) 2027 (38%)
t max (h) 2.1 (61%) 2.5 (55%)
CL/f (L/h) 9.2 (37%) 11.4 (42%)

Weight unadjusted apparent clearance was 11.4 L/h (42%) in the 7-11 year oldchildren and 9.2 L/h (37%) in the 5-6 year old children, which resulted in greatersystemic drug exposures than that obtained in adults for an identical dose allergies and genetically modified organisms. To maintain similar exposure levels in children compared to adults, a dose of10 mg twice daily is recommended in children 5-11 years of age (see DOSAGE ANDADMINISTRATION ) allergies and genetically modified organisms.

Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults allergies and genetically modified organisms.

Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects allergies and genetically modified organisms.

Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects allergies and genetically modified organisms.

Drug-Drug Interactions
The following drug interaction studies have been conducted with zafirlukast(see PRECAUTIONS , Drug Interactions ) allergies and genetically modified organisms.

Coadministration of multiple doses of zafirlukast (160 mg/day) to steady-statewith a single 25 mg dose of warfarin (a substrate of CYP2C9) resulted in a significantincrease in the mean AUC (+63%) and half-life (+36%) of S-warfarin allergies and genetically modified organisms. The meanprothrombin time increased by approximately 35% allergies and genetically modified organisms. The pharmacokinetics of zafirlukastwere unaffected by coadministration with warfarin allergies and genetically modified organisms.
Coadministration of zafirlukast (80 mg/day) at steady-state with a single doseof a liquid theophylline preparation (6 mg/kg) in 13 asthmatic patients, 18to 44 years of age, resulted in decreased mean plasma concentrations of zafirlukastby approximately 30%, but no effect on plasma theophylline concentrations wasobserved allergies and genetically modified organisms.
Coadministration of zafirlukast (20 mg/day) or placebo at steady-state witha single dose of sustained release theophylline preparation (16 mg/kg) in 16healthy boys and girls (6 through 11 years of age) resulted in no significantdifferences in the pharmacokinetic parameters of theophylline allergies and genetically modified organisms.
Coadministration of zafirlukast dosed at 40 mg twice daily in a single-blind,parallel-group, 3-week study in 39 healthy female subjects taking oral contraceptives,resulted in no significant effect on ethinyl estradiol plasma concentrationsor contraceptive efficacy allergies and genetically modified organisms.
Coadministration of zafirlukast (40 mg/day) with aspirin (650 mg four timesdaily) resulted in mean increased plasma concentrations of zafirlukast by approximately45% allergies and genetically modified organisms.
Coadministration of a single dose of zafirlukast (40 mg) with erythromycin (500mg three times daily for 5 days) to steady-state in 11 asthmatic patients resultedin decreased mean plasma concentrations of zafirlukast by approximately 40%due to a decrease in zafirlukast bioavailability allergies and genetically modified organisms.

symptom diary asthma infant cat allergies how to control what causes asthma sulfite allergy control asthma asthma and running environmental allergies yoga asthma asthma attack symptoms does accolate clear eczema allergy induced asthma asthma plan chiropractics and asthma allergy relief medicine food allergy cure allergy relief for dogs homeopathy asthma silicofluoride treated water and asthma allergies to dogs allergy report child allergy national allergy fall allergies lung congestion national institute of allergy and infectious diseases dog food allergies allergies home remedies accolate allergies and skin rashes asthma canada asthma inflammation epidemiology and asthma asthma and wood heat pictures of asthma small asthma spacer accolate peak flow age does second hand smoke cause asthma asthma care in canada sheltie allergies food allergies acrylic allergy milk allergies babies aspirin allergy fact sheet for asthma signs of asthma asthma questionnaire asthma pediatric high flow nebulizers yeast allergy symptoms drug effects on asthma treatment of asthma asthma prognosis allergy skin rash pictures seasonal asthma asthma medication side effects asthma in the military asthma inflammation new asthma medications symptom diary asthma infant allergy supplies milk allergies linked to behavior problems children allergies medication information accolate milk allergies linked to behavior problems mold mildew allergies allergy care centers virginia asthma scholarship asthma guidelines asthma and allergy foundation asthma medication

abilify abraxane accolate accupril accutane acetaminophen aciphex aclovate actifed activase actiza actonel actos aczone adacel adalat adderall adipex advair advate agilect albalon albuterol aldomet alesse aleve alimta allegra aloxi alphagan alprazolam altace altocor alvesco amaryl ambien amiodarone amitriptyline amoxicillin androgel angeliq anidulafungin antabuse antegren anusol apidra apokyn arthrotec asacol aspirin atenolol ativan augmentin avandia avapro avastin avelox axid

aallergies and genetically modified organisms alllergies and genetically modified organisms alllergies and genetically modified organisms alleergies and genetically modified organisms allerrgies and genetically modified organisms allerggies and genetically modified organisms allergiies and genetically modified organisms allergiees and genetically modified organisms allergiess and genetically modified organisms allergies and genetically modified organisms allergies aand genetically modified organisms allergies annd genetically modified organisms allergies andd genetically modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and ggenetically modified organisms allergies and geenetically modified organisms allergies and gennetically modified organisms allergies and geneetically modified organisms allergies and genettically modified organisms allergies and genetiically modified organisms allergies and geneticcally modified organisms allergies and geneticaally modified organisms allergies and geneticallly modified organisms allergies and geneticallly modified organisms allergies and geneticallyy modified organisms allergies and genetically modified organisms allergies and genetically mmodified organisms allergies and genetically moodified organisms allergies and genetically moddified organisms allergies and genetically modiified organisms allergies and genetically modiffied organisms allergies and genetically modifiied organisms allergies and genetically modifieed organisms allergies and genetically modifiedd organisms allergies and genetically modified organisms allergies and genetically modified oorganisms allergies and genetically modified orrganisms allergies and genetically modified orgganisms allergies and genetically modified orgaanisms allergies and genetically modified organnisms allergies and genetically modified organiisms allergies and genetically modified organissms allergies and genetically modified organismms allergies and genetically modified organismss llergies and genetically modified organisms alergies and genetically modified organisms alergies and genetically modified organisms allrgies and genetically modified organisms allegies and genetically modified organisms alleries and genetically modified organisms allerges and genetically modified organisms allergis and genetically modified organisms allergie and genetically modified organisms allergiesand genetically modified organisms allergies nd genetically modified organisms allergies ad genetically modified organisms allergies an genetically modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and enetically modified organisms allergies and gnetically modified organisms allergies and geetically modified organisms allergies and gentically modified organisms allergies and geneically modified organisms allergies and genetcally modified organisms allergies and genetially modified organisms allergies and geneticlly modified organisms allergies and geneticaly modified organisms allergies and geneticaly modified organisms allergies and geneticall modified organisms allergies and geneticallymodified organisms allergies and genetically odified organisms allergies and genetically mdified organisms allergies and genetically moified organisms allergies and genetically modfied organisms allergies and genetically modiied organisms allergies and genetically modifed organisms allergies and genetically modifid organisms allergies and genetically modifie organisms allergies and genetically modifiedorganisms allergies and genetically modified rganisms allergies and genetically modified oganisms allergies and genetically modified oranisms allergies and genetically modified orgnisms allergies and genetically modified orgaisms allergies and genetically modified organsms allergies and genetically modified organims allergies and genetically modified organiss allergies and genetically modified organism a llergies and genetically modified organisms al lergies and genetically modified organisms all ergies and genetically modified organisms alle rgies and genetically modified organisms aller gies and genetically modified organisms allerg ies and genetically modified organisms allergi es and genetically modified organisms allergie s and genetically modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies a nd genetically modified organisms allergies an d genetically modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and g enetically modified organisms allergies and ge netically modified organisms allergies and gen etically modified organisms allergies and gene tically modified organisms allergies and genet ically modified organisms allergies and geneti cally modified organisms allergies and genetic ally modified organisms allergies and genetica lly modified organisms allergies and genetical ly modified organisms allergies and geneticall y modified organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and genetically m odified organisms allergies and genetically mo dified organisms allergies and genetically mod ified organisms allergies and genetically modi fied organisms allergies and genetically modif ied organisms allergies and genetically modifi ed organisms allergies and genetically modifie d organisms allergies and genetically modified organisms allergies and genetically modified organisms allergies and genetically modified o rganisms allergies and genetically modified or ganisms allergies and genetically modified org anisms allergies and genetically modified orga nisms allergies and genetically modified organ isms allergies and genetically modified organi sms allergies and genetically modified organis ms allergies and genetically modified organism s allergies and genetically modified organisms lalergies and genetically modified organisms allergies and genetically modified organisms alelrgies and genetically modified organisms allregies and genetically modified organisms allegries and genetically modified organisms alleriges and genetically modified organisms allergeis and genetically modified organisms allergise and genetically modified organisms allergie sand genetically modified organisms allergiesa nd genetically modified organisms allergies nad genetically modified organisms allergies adn genetically modified organisms allergies an d genetically modified organisms allergies and genetically modified organisms allergies and g enetically modified organisms allergies and egnetically modified organisms allergies and gneetically modified organisms allergies and geentically modified organisms allergies and genteically modified organisms allergies and geneitcally modified organisms allergies and genetcially modified organisms allergies and genetiaclly modified organisms allergies and geneticlaly modified organisms allergies and genetically modified organisms allergies and geneticalyl modified organisms allergies and geneticall ymodified organisms allergies and geneticallym odified organisms allergies and genetically omdified organisms allergies and genetically mdoified organisms allergies and genetically moidfied organisms allergies and genetically modfiied organisms allergies and genetically modiifed organisms allergies and genetically modifeid organisms allergies and genetically modifide organisms allergies and genetically modifie dorganisms allergies and genetically modifiedo rganisms allergies and genetically modified roganisms allergies and genetically modified ogranisms allergies and genetically modified oragnisms allergies and genetically modified orgnaisms allergies and genetically modified orgainsms allergies and genetically modified organsims allergies and genetically modified organimss allergies and genetically modified organissm aallergies and genetically modified organisms theallergies and genetically modified organisms allergies and genetically modified organisms

a b c d e f g h i k l m n o p r s t u v w x z